Synexa Life Sciences combines expertise in pharmacokinetics, immunogenicity, biomarkers, proteomics, and translational science to support clinical development from early-phase studies through to pivotal trials.

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation, and delivery of a wide range of complex and custom-designed assays. With a team of over 200 staff across 3 global laboratory locations; Manchester, Cape Town and Turku (Finland), we provide innovative solutions to support our customers achieve their clinical milestones. Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry and ELISpot) and genetic services to support clinical trials and translational studies. We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis. Synexa, improving the quality of human health through innovative biomarker and bioanalytical solutions.